May 15, 2023

Regenstrief researcher featured speaker at UsAgainstAlzheimer’s event in Washington, DC

Dr. Nicole Fowler speaking at the UsAgainstAlzheimer's Brain Health Bash in Washington, D.C.

Regenstrief Research Scientist Nicole Fowler, PhD, MHSA, was the featured speaker at an UsAgainstAlzheimer’s event in Washington, D.C. The event was the inaugural Brain Health Bash which focuses on spotlighting the importance of Alzheimer’s prevention and dementia risk reduction.

Dr. Fowler’s research foci include patient-centered diagnosis and treatment and her goal is to improve the quality of care and quality of life for older adults with dementia and their family caregivers.

UsAgainstAlzheimer’s is a national leader in Alzheimer’s care and focuses on prevention, early detection and diagnosis, and access to treatments – regardless of gender, race, or ethnicity.  The organization seeks to give a voice to patients and caregivers while partnering with the government, scientists, the private sector and their allied organizations. A few notable partners are Eli Lilly and Company, EISAI Co., Alzheimer’s Drug Discovery Foundation and Biogen.

Dr. Fowler standing with Jill Lesser, President, WomenAgainstAlzheimer's, and a top health podcaster Max Lugavere.
Dr. Fowler (left) standing with Jill Lesser, President, WomenAgainstAlzheimer’s, and a top health podcaster Max Lugavere.

During her presentation on April 18, Dr. Fowler, who is also the associate director of the Indiana University Center for Aging Research at Regenstrief Institute and an associate professor at Indiana University School of Medicine, topics discussed were about the data for early detection of dementia, the importance of systems of care and how to ensure persons with dementia and their family that they are supported at all stages of the disease.

As a Regenstrief research scientist, her work is focused on the development, testing and comparison of evidence-based and patient-centered interventions that improve the quality of care for older adults and their family caregivers, in particular medical decision-making interventions to support family caregivers of older adults with Alzheimer’s disease.

Dr. Fowler’s research to has been funded by multiple foundations along with the National Institutes of Health and the U.S. Department of Defense.

About Nicole R. Fowler, PhD, MHSA
In addition to her role as associate director of the Indiana University Center for Aging Research at Regenstrief Institute, Nicole R. Fowler, PhD, MHSA, is also an associate professor of medicine at Indiana University School of Medicine and director of research for the Division of General Internal Medicine and Geriatrics. She also is an implementation scientist in the Center for Health and Innovation and Implementation Science and a scientist at the Indiana Alzheimer Disease Research Center.

About Regenstrief Institute
Founded in 1969 in Indianapolis, the Regenstrief Institute is a local, national and global leader dedicated to a world where better information empowers people to end disease and realize true health. A key research partner to Indiana University, Regenstrief and its research scientists are responsible for a growing number of major healthcare innovations and studies. Examples range from the development of global health information technology standards that enable the use and interoperability of electronic health records to improving patient-physician communications, to creating models of care that inform practice and improve the lives of patients around the globe.

Sam Regenstrief, a nationally successful entrepreneur from Connersville, Indiana, founded the institute with the goal of making healthcare more efficient and accessible for everyone. His vision continues to guide the institute’s research mission.

Related News

EHR-based public health surveillance for chronic diseases

EHR-based public health surveillance for chronic diseases

There are political, legal and organizational barriers to overcome but sharing data with public health could improve chronic disease

Nir Menachemi, PhD

Untreated mental illness costs Indiana more than $4 billion each year

Research team creates framework that can be applied across the U.S. A new study reveals the economic burden of

graphic showing some of the results of interhospital transfer for dementia patients

Understanding the impact of transferring patients with dementia between hospitals

Benefits may not always outweigh the risks for this vulnerable population. It is common for individuals seeking medical care